<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Have | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/tailliver9/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/tailliver9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Have.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">d108662fe08c81fc952548e5fedae686</guid>
				<title>Have posted an update: The emergence of these improved treatment options will [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40676/</link>
				<pubDate>Fri, 07 Feb 2025 08:48:36 -0800</pubDate>

									<content:encoded><![CDATA[<p>The emergence of these improved treatment options will presumably change current HAE guidelines, but adherence to these recommendations may become restricted by high treatment costs. It will therefore be essential to determine the indications and identify the patients that will benefit most from these newest treatment generations. Ultimately,&hellip;<span class="activity-read-more" id="activity-read-more-40676"><a href="http://www.nationalboardinstitute.com/activity/p/40676/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0a9733923ee555b5dae313929e3cd2ac</guid>
				<title>Have posted an update: 73 ± 70.71 vs 271.95 ± 67.40, P = .002).







 The use o [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39500/</link>
				<pubDate>Thu, 06 Feb 2025 08:36:46 -0800</pubDate>

									<content:encoded><![CDATA[<p>73 ± 70.71 vs 271.95 ± 67.40, P = .002).</p>
<p> The use of continuous milk warming improves weight gain in very low birth-weight infants.</p>
<p>The use of continuous milk warming improves weight gain in very low birth-weight infants.</p>
<p> Standardized parenteral nutrition (PN) formulations are used in at-risk neonates to provide nutrition i&hellip;<span class="activity-read-more" id="activity-read-more-39500"><a href="http://www.nationalboardinstitute.com/activity/p/39500/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d92aa74a406ef20e39c17085496ecf64</guid>
				<title>Have posted an update: An anova was used to analyze the differences in means before [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37900/</link>
				<pubDate>Tue, 04 Feb 2025 08:34:10 -0800</pubDate>

									<content:encoded><![CDATA[<p>An anova was used to analyze the differences in means before and after training. An ancova was also performed to determine the effects of the intervention. RESULTS The results revealed a significant difference between pre- and post-intervention emotional exhaustion and depersonalization scores. Personal accomplishment scores improved, but the&hellip;<span class="activity-read-more" id="activity-read-more-37900"><a href="http://www.nationalboardinstitute.com/activity/p/37900/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">04d0aae1a76647e76604734ae8ea713b</guid>
				<title>Have posted an update: Among other results, we found a differential expression of [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36125/</link>
				<pubDate>Sun, 02 Feb 2025 08:40:58 -0800</pubDate>

									<content:encoded><![CDATA[<p>Among other results, we found a differential expression of vitronectin (VTN) in patients displaying chronic interstitial and tubular lesions (ci and ct mean &gt; 2 according to Banff criteria). These results were further confirmed by a pilot study using enzyme-linked immunosorbent assay (ELISA).</p>
<p> Urinary vitronectin levels are a potential sta&hellip;<span class="activity-read-more" id="activity-read-more-36125"><a href="http://www.nationalboardinstitute.com/activity/p/36125/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">18a69b2b7ef41c4ca9f69fc7aef65bd0</guid>
				<title>Have posted an update: Promotional activities of pharmaceutical companies (Pharma) [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34380/</link>
				<pubDate>Fri, 31 Jan 2025 08:32:13 -0800</pubDate>

									<content:encoded><![CDATA[<p>Promotional activities of pharmaceutical companies (Pharma) relating to newly marketed direct-acting antivirals (DAAs) may have targeted the authors of the Japanese Clinical Practice Guidelines (CPGs) for Hepatitis C. This study aimed to assess payments made by Pharma to the CPG authors and the financial conflicts of interest (FCOIs) reported by&hellip;<span class="activity-read-more" id="activity-read-more-34380"><a href="http://www.nationalboardinstitute.com/activity/p/34380/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a826617cb2dea5cb9c9179ecbf763242</guid>
				<title>Have posted an update: To evaluate the applicability of the Mimosa tenuiflora and [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32850/</link>
				<pubDate>Wed, 29 Jan 2025 08:27:46 -0800</pubDate>

									<content:encoded><![CDATA[<p>To evaluate the applicability of the Mimosa tenuiflora and Eucalyptus urograndis pyroligneous acids (PAs) as alternative antiseptics in dairy goats.</p>
<p> Cytotoxicity was evaluated in vitro using bacteria, as well as in vivo using goats, and the influence of PAs on the physicochemical parameters of fresh milk were examined. The cytotoxicity of&hellip;<span class="activity-read-more" id="activity-read-more-32850"><a href="http://www.nationalboardinstitute.com/activity/p/32850/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d33cb32ee12eaf1fd7195563429403ad</guid>
				<title>Have posted an update: The genomic analysis of virulence factors led to [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28026/</link>
				<pubDate>Tue, 28 Jan 2025 10:26:54 -0800</pubDate>

									<content:encoded><![CDATA[<p>The genomic analysis of virulence factors led to identification of a type VI secretion system, hemolysin, filamentous hemagglutinin, and genes involved in iron uptake and sequestration. Finally, the data provided here show that, the KM1 isolate exerted strong immunostimulatory properties on RAW 264.7 macrophages in vitro. Stimulated cells produced&hellip;<span class="activity-read-more" id="activity-read-more-28026"><a href="http://www.nationalboardinstitute.com/activity/p/28026/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f1fac1ac93d9c437f8f86e60ac580c43</guid>
				<title>Have became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/27908/</link>
				<pubDate>Tue, 28 Jan 2025 10:19:46 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>